glp-1+gip GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Indications for GLP-1/GIP RA Summary

How could they not

Make sure you eat enough Wegovy significantly reduces appetite, and some people find it difficult to eat enough, particularly in the early weeks of treatment

There's also a timing component

A large number of acquired nevi and the presence of clinically atypical nevi each represents a marker of increased risk for development of melanoma, and patients with either trait should be followed with periodic total body skin examinations beginning around puberty

Fujitsuka N, Asakawa A, Uezono Y, Minami K, Yamaguchi T, Niijima A, Yada T, Maejima Y, Sedbazar U, Sakai T, Hattori T, Kase Y, Inui A

Genomic data in the All of Us Research Program